β-Adrenergic Receptor-Mediated Cardiac Contractility is Inhibited via Vasopressin Type 1A-Receptor-Dependent Signaling

BACKGROUND: Enhanced arginine vasopressin (AVP) levels are associated with increased mortality during end-stage human heart failure (HF), and cardiac AVP type 1A receptor (V1AR) expression becomes increased. Additionally, mice with cardiac-restricted V1AR overexpression develop cardiomyopathy and de...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Circulation
Prif Awduron: Tilley, Douglas G., Zhu, Weizhong, Myers, Valerie D., Barr, Larry A., Gao, Erhe, Li, Xue, Song, Jianliang, Carter, Rhonda L., Makarewich, Catherine A., Yu, Daohai, Troupes, Constantine D., Grisanti, Laurel A., Coleman, Ryan C., Koch, Walter J., Houser, Steven R., Cheung, Joseph Y., Feldman, Arthur M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229385/
https://ncbi.nlm.nih.gov/pubmed/25205804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.114.010434
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg